WELL:XETRA:XETRA-HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 17.822

Change

+0.20 (+1.12)%

Market Cap

N/A

Volume

1.75K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

+0.56 (+1.23%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.76 (+0.77%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.32 (+1.34%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

+0.16 (+1.19%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

+0.09 (+1.59%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

+0.26 (+1.10%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

+0.12 (+0.93%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

-0.52 (-0.90%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

+0.08 (+0.79%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

+0.20 (+0.16%)

USD 12.26B

ETFs Containing WELL:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -10.46% 12% F 14% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -10.46% 17% F 18% F
Trailing 12 Months  
Capital Gain 1.54% 36% F 40% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.54% 40% F 43% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 21.58% 93% A 91% A-
Dividend Return 21.63% 93% A 90% A-
Total Return 0.05% 14% F 8% B-
Risk Return Profile  
Volatility (Standard Deviation) 22.80% 14% F 26% F
Risk Adjusted Return 94.88% 83% B 85% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.